Skip to main content
Log in

Expanded screening for Ashkenazi Jewish women worth it in UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Manchanda R, et al. Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing. Journal of the National Cancer Institute 107: No. 1, Jan 2015. Available from: URL: http://doi.org/10.1093/jnci/dju380

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Expanded screening for Ashkenazi Jewish women worth it in UK. PharmacoEcon Outcomes News 718, 20 (2014). https://doi.org/10.1007/s40274-014-1785-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1785-z

Navigation